Other News To Note
Wednesday, May 1, 2013
Pluristem Therapeutics Inc., of Haifa, Israel, said independent researchers from the University of Queensland, Australia, showed blood flow was maintained with no adverse hemodynamic effects following infusion of the company's placental eXpanded (PLX) cells in a human lung model of pulmonary arterial hypertension.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.